{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:03:25Z","timestamp":1790485405293,"version":"4.1.0"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) belongs to the group of Betacoronaviruses. The SARS-CoV-2 is closely related to SARS-CoV-1\u00a0and probably originated either from bats or pangolins. SARS-CoV-2 is an etiological agent of COVID-19, causing mild to severe respiratory disease which escalates to acute respiratory distress syndrome (ARDS) or multi-organ failure. The virus was first reported from the animal market in Hunan, Hubei province of China in the month of December, 2019, and was\u00a0rapidly transmitted from animal to human and human-to-human. The human-to-human transmission can occur directly or via droplets generated during coughing and sneezing. Globally, around 53.9 million cases of COVID-19 have been registered with 1.31 million confirmed deaths. The people\u2009&gt;\u200960\u00a0years,\u00a0persons suffering from comorbid conditions and\u00a0immunocompromised individuals are more susceptible to COVID-19 infection. The virus primarily targets the upper and the lower respiratory tract and quickly disseminates to other organs. SARS-CoV-2 dysregulates immune signaling pathways which generate cytokine storm and leads to the acute respiratory distress syndrome\u00a0and other multisystemic disorders.<\/jats:p>","DOI":"10.1186\/s12931-020-01581-z","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T08:04:14Z","timestamp":1606809854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["SARS coronavirus 2: from genome to infectome"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0240-2068","authenticated-orcid":false,"given":"Meghana","family":"Rastogi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0900-019X","authenticated-orcid":false,"given":"Neha","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0833-8693","authenticated-orcid":false,"given":"Astha","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8802-1169","authenticated-orcid":false,"given":"Sunit K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"1581_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/bmj.2.5297.82","volume":"2","author":"EJ Kendall","year":"1962","unstructured":"Kendall EJ, Bynoe ML, Tyrrell DA. Virus isolations from common colds occurring in a residential school. BMJ. 1962;2:82\u20136.","journal-title":"BMJ"},{"key":"1581_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nrmicro2147","volume":"7","author":"S Perlman","year":"2009","unstructured":"Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol. 2009;7:439\u201350.","journal-title":"Nat Rev Microbiol"},{"key":"1581_CR3","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S0140-6736(03)14630-2","volume":"362","author":"NS Zhong","year":"2003","unstructured":"Zhong NS, Zheng BJ, Li YM, Poon, Xie ZH, Chan KH, Li PH, Tan SY, Chang Q, Xie JP, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People\u2019s Republic of China, in February, 2003. Lancet. 2003;362:1353\u20138.","journal-title":"Lancet"},{"key":"1581_CR4","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","volume":"367","author":"AM Zaki","year":"2012","unstructured":"Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814\u201320.","journal-title":"N Engl J Med"},{"key":"1581_CR5","doi-asserted-by":"publisher","first-page":"e1006698","DOI":"10.1371\/journal.ppat.1006698","volume":"13","author":"B Hu","year":"2017","unstructured":"Hu B, Zeng LP, Yang XL, Ge XY, Zhang W, Li B, Xie JZ, Shen XR, Zhang YZ, Wang N, et al. Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. PLoS Pathog. 2017;13:e1006698.","journal-title":"PLoS Pathog"},{"key":"1581_CR6","doi-asserted-by":"publisher","first-page":"8638","DOI":"10.1128\/JVI.01055-13","volume":"87","author":"SK Lau","year":"2013","unstructured":"Lau SK, Li KS, Tsang AK, Lam CS, Ahmed S, Chen H, Chan KH, Woo PC, Yuen KY. Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus. J Virol. 2013;87:8638\u201350.","journal-title":"J Virol"},{"key":"1581_CR7","unstructured":"WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020."},{"key":"1581_CR8","unstructured":"Statement on the Second Meeting of the International Health Regulations. Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). 2005. https:\/\/www.who.int\/news-room\/detail\/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)."},{"key":"1581_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265\u20139.","journal-title":"Nature"},{"key":"1581_CR10","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.3390\/v2081803","volume":"2","author":"PC Woo","year":"2010","unstructured":"Woo PC, Huang Y, Lau SK, Yuen KY. Coronavirus genomics and bioinformatics analysis. Viruses. 2010;2:1804\u201320.","journal-title":"Viruses"},{"key":"1581_CR11","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.cub.2020.03.022","volume":"30","author":"T Zhang","year":"2020","unstructured":"Zhang T, Wu Q, Zhang Z. Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Curr Biol. 2020;30:1346-1351.e1342.","journal-title":"Curr Biol"},{"key":"1581_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","volume":"14","author":"X Zou","year":"2020","unstructured":"Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020;14:185\u201392.","journal-title":"Front Med"},{"key":"1581_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420\u20132.","journal-title":"Lancet Respir Med"},{"key":"1581_CR14","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Q Li","year":"2020","unstructured":"Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199\u2013207.","journal-title":"N Engl J Med"},{"key":"1581_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/v12020135","volume":"12","author":"LE Gralinski","year":"2020","unstructured":"Gralinski LE, Menachery VD. Return of the coronavirus: 2019-nCoV. Viruses. 2020;12:135.","journal-title":"Viruses"},{"key":"1581_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, Li B, Huang C-L, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270\u20133.","journal-title":"Nature"},{"key":"1581_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3389\/fvets.2020.00379","volume":"7","author":"S Yuan","year":"2020","unstructured":"Yuan S, Jiang SC, Li ZL. Analysis of possible intermediate hosts of the new coronavirus SARS-CoV-2. Front Vet Sci. 2020;7:379.","journal-title":"Front Vet Sci"},{"key":"1581_CR18","doi-asserted-by":"crossref","unstructured":"Ren L, Wu C, Guo L, Yao J, Wang C, Xiao Y, Pisco AO, Wu Z, Lei X, Liu Y, et al. Single-cell transcriptional atlas of the Chinese horseshoe bat (Rhinolophus sinicus) provides insight into the cellular mechanisms which enable bats to be viral reservoirs. 2020:2020.2006.2030.175778.","DOI":"10.1101\/2020.06.30.175778"},{"key":"1581_CR19","unstructured":"Coronavirus Pandemic COVID-19 Statistics and Research. https:\/\/ourworldindata.org\/coronavirus#acknowledgements."},{"key":"1581_CR20","doi-asserted-by":"publisher","first-page":"9696","DOI":"10.1073\/pnas.2004911117","volume":"117","author":"JB Dowd","year":"2020","unstructured":"Dowd JB, Andriano L, Brazel DM, Rotondi V, Block P, Ding X, Liu Y, Mills MC. Demographic science aids in understanding the spread and fatality rates of COVID-19. Proc Natl Acad Sci USA. 2020;117:9696\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1581_CR21","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41591-020-0822-7","volume":"26","author":"JT Wu","year":"2020","unstructured":"Wu JT, Leung K, Bushman M, Kishore N, Niehus R, de Salazar PM, Cowling BJ, Lipsitch M, Leung GM. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat Med. 2020;26:506\u201310.","journal-title":"Nat Med"},{"key":"1581_CR22","first-page":"1775","volume":"323","author":"G Onder","year":"2020","unstructured":"Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323:1775\u20136.","journal-title":"JAMA"},{"key":"1581_CR23","doi-asserted-by":"crossref","unstructured":"Venkatesan P. The changing demographics of COVID-19. Lancet Respir Med. 2020.","DOI":"10.1016\/S2213-2600(20)30461-6"},{"key":"1581_CR24","unstructured":"Mortality Risk of COVID-19 Statistics and Research [https:\/\/ourworldindata.org\/mortality-risk-covid]"},{"key":"1581_CR25","doi-asserted-by":"crossref","unstructured":"Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, Hosein Z, Padda I, Mangat J, Altaf M. Comorbidity and its impact on patients with COVID-19. SN Compr Clin Med. 2020:1\u20138.","DOI":"10.1007\/s42399-020-00363-4"},{"key":"1581_CR26","doi-asserted-by":"crossref","unstructured":"Ma C, Gu J, Hou P, Zhang L, Bai Y, Guo Z, Wu H, Zhang B, Li P, Zhao X. Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. 2020:2020.2003.2017.20037572.","DOI":"10.1101\/2020.03.17.20037572"},{"key":"1581_CR27","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ijid.2020.08.065","volume":"100","author":"RA Ghayda","year":"2020","unstructured":"Ghayda RA, Lee KH, Han YJ, Ryu S, Hong SH, Yoon S, Jeong GH, Lee J, Lee JY, Yang JW, et al. Estimation of global case fatality rate of coronavirus disease 2019 (COVID-19) using meta-analyses: comparison between calendar date and days since the outbreak of the first confirmed case. Int J Infect Dis. 2020;100:302\u20138.","journal-title":"Int J Infect Dis"},{"key":"1581_CR28","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1111\/all.14238","volume":"75","author":"JJ Zhang","year":"2020","unstructured":"Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75:1730\u201341.","journal-title":"Allergy"},{"key":"1581_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fpubh.2020.00152","volume":"8","author":"JM Jin","year":"2020","unstructured":"Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, Liu S, Yang JK. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152.","journal-title":"Front Public Health"},{"key":"1581_CR30","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, the Northwell C-RC, Barnaby DP, Becker LB, Chelico JD, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052\u20139.","journal-title":"JAMA"},{"key":"1581_CR31","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1093\/eurheartj\/ehaa373","volume":"41","author":"IE Sama","year":"2020","unstructured":"Sama IE, Ravera A, Santema BT, van Goor H, Ter Maaten JM, Cleland JGF, Rienstra M, Friedrich AW, Samani NJ, Ng LL, et al. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. 2020;41:1810\u20137.","journal-title":"Eur Heart J"},{"key":"1581_CR32","doi-asserted-by":"publisher","first-page":"E63","DOI":"10.5888\/pcd17.200247","volume":"17","author":"DM Griffith","year":"2020","unstructured":"Griffith DM, Sharma G, Holliday CS, Enyia OK, Valliere M, Semlow AR, Stewart EC, Blumenthal RS. Men and COVID-19: a biopsychosocial approach to understanding sex differences in mortality and recommendations for practice and policy interventions. Prev Chronic Dis. 2020;17:E63.","journal-title":"Prev Chronic Dis"},{"key":"1581_CR33","doi-asserted-by":"publisher","first-page":"taa008","DOI":"10.1093\/jtm\/taaa008","volume":"27","author":"II Bogoch","year":"2020","unstructured":"Bogoch II, Watts A, Thomas-Bachli A, Huber C, Kraemer MUG, Khan K. Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel. J Travel Med. 2020;27:taa008.","journal-title":"J Travel Med"},{"key":"1581_CR34","unstructured":"Khan S, Siddique R, Shereen MA, Ali A, Liu J, Bai Q, Bashir N, Xue M. The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options. J Clin Microbiol. 2020."},{"key":"1581_CR35","doi-asserted-by":"publisher","first-page":"P7","DOI":"10.1164\/rccm.2014P7","volume":"201","author":"WG Carlos","year":"2020","unstructured":"Carlos WG, Dela Cruz CS, Cao B, Pasnick S, Jamil S. Novel Wuhan (2019-nCoV) coronavirus. Am J Respir Crit Care Med. 2020;201:P7\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"1581_CR36","doi-asserted-by":"publisher","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","volume":"109","author":"HA Rothan","year":"2020","unstructured":"Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433.","journal-title":"J Autoimmun"},{"key":"1581_CR37","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa2001191","volume":"382","author":"ML Holshue","year":"2020","unstructured":"Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382:929\u201336.","journal-title":"N Engl J Med"},{"key":"1581_CR38","doi-asserted-by":"publisher","first-page":"799","DOI":"10.5858\/arpa.2020-0901-SA","volume":"144","author":"DA Schwartz","year":"2020","unstructured":"Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med. 2020;144:799\u2013805.","journal-title":"Arch Pathol Lab Med"},{"key":"1581_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.21037\/atm.2020.02.20","volume":"8","author":"L Wang","year":"2020","unstructured":"Wang L, Shi Y, Xiao T, Fu J, Feng X, Mu D, Feng Q, Hei M, Hu X, Li Z, et al. Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (First edition). Ann Transl Med. 2020;8:47.","journal-title":"Ann Transl Med"},{"key":"1581_CR40","unstructured":"Coronavirus: The world in lockdown in maps and charts. https:\/\/www.bbc.com\/news\/world-52103747."},{"key":"1581_CR41","first-page":"9","volume":"2020","author":"HM Ashour","year":"2019","unstructured":"Ashour HM, Elkhatib WF, Rahman MM, Elshabrawy HA: Insights into the Recent, . Novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks. Pathogens. 2019;2020:9.","journal-title":"Pathogens"},{"key":"1581_CR42","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1128\/JVI.06540-11","volume":"86","author":"PCY Woo","year":"2012","unstructured":"Woo PCY, Lau SKP, Lam CSF, Lau CCY, Tsang AKL, Lau JHN, Bai R, Teng JLL, Tsang CCC, Wang M, et al. Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. J Virol. 2012;86:3995\u20134008.","journal-title":"J Virol"},{"key":"1581_CR43","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565\u201374.","journal-title":"Lancet"},{"key":"1581_CR44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cell.2020.03.035","volume":"181","author":"YZ Zhang","year":"2020","unstructured":"Zhang YZ, Holmes EC. A genomic perspective on the origin and emergence of SARS-CoV-2. Cell. 2020;181:223\u20137.","journal-title":"Cell"},{"key":"1581_CR45","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/pathogens9030240","volume":"9","author":"SU Rehman","year":"2020","unstructured":"Rehman SU, Shafique L, Ihsan A, Liu Q. Evolutionary trajectory for the emergence of novel coronavirus SARS-CoV-2. Pathogens. 2020;9:240.","journal-title":"Pathogens"},{"key":"1581_CR46","doi-asserted-by":"crossref","unstructured":"Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020;94.","DOI":"10.1128\/JVI.00127-20"},{"issue":"281\u2013292","key":"1581_CR47","first-page":"e286","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(281\u2013292):e286.","journal-title":"Cell"},{"key":"1581_CR48","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","volume":"26","author":"KG Andersen","year":"2020","unstructured":"Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020;26:450\u20132.","journal-title":"Nat Med"},{"key":"1581_CR49","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41586-020-2169-0","volume":"583","author":"TT Lam","year":"2020","unstructured":"Lam TT, Shum MH, Zhu HC, Tong YG, Ni XB, Liao YS, Wei W, Cheung WY, Li WJ, Li LF, et al. Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins. Nature. 2020;583:282\u20135.","journal-title":"Nature"},{"key":"1581_CR50","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41586-020-2313-x","volume":"583","author":"K Xiao","year":"2020","unstructured":"Xiao K, Zhai J, Feng Y, Zhou N, Zhang X, Zou JJ, Li N, Guo Y, Li X, Shen X, et al. Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins. Nature. 2020;583:286\u20139.","journal-title":"Nature"},{"key":"1581_CR51","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3390\/v11110979","volume":"11","author":"P Liu","year":"2019","unstructured":"Liu P, Chen W, Chen JP. Viral metagenomics revealed sendai virus and coronavirus infection of malayan pangolins (Manis javanica). Viruses. 2019;11:979.","journal-title":"Viruses"},{"key":"1581_CR52","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1126\/science.abb7015","volume":"368","author":"J Shi","year":"2020","unstructured":"Shi J, Wen Z, Zhong G, Yang H, Wang C, Huang B, Liu R, He X, Shuai L, Sun Z, et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. 2020;368:1016\u201320.","journal-title":"Science"},{"issue":"704\u2013709","key":"1581_CR53","first-page":"e702","volume":"27","author":"YI Kim","year":"2020","unstructured":"Kim YI, Kim SG, Kim SM, Kim EH, Park SJ, Yu KM, Chang JH, Kim EJ, Lee S, Casel MAB, et al. Infection and rapid transmission of SARS-CoV-2 in Ferrets. Cell Host Microbe. 2020;27(704\u2013709):e702.","journal-title":"Cell Host Microbe"},{"key":"1581_CR54","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1038\/s41467-020-17367-2","volume":"11","author":"M Richard","year":"2020","unstructured":"Richard M, Kok A, de Meulder D, Bestebroer TM, Lamers MM, Okba NMA, Fentener van Vlissingen M, Rockx B, Haagmans BL, Koopmans MPG, et al. SARS-CoV-2 is transmitted via contact and via the air between ferrets. Nat Commun. 2020;11:3496.","journal-title":"Nat Commun"},{"key":"1581_CR55","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","volume":"27","author":"A Wu","year":"2020","unstructured":"Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, Meng J, Zhu Z, Zhang Z, Wang J, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27:325\u20138.","journal-title":"Cell Host Microbe"},{"key":"1581_CR56","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727\u201333.","journal-title":"N Engl J Med"},{"key":"1581_CR57","doi-asserted-by":"crossref","unstructured":"Kim D, Lee J-Y, Yang J-S, Kim JW, Kim VN, Chang H. The architecture of SARS-CoV-2 transcriptome. Cell-Press. 2020:2020.2003.2012.988865.","DOI":"10.1101\/2020.03.12.988865"},{"key":"1581_CR58","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507\u201313.","journal-title":"Lancet"},{"key":"1581_CR59","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1073\/pnas.0805270106","volume":"106","author":"M B\u00e1rcena","year":"2009","unstructured":"B\u00e1rcena M, Oostergetel GT, Bartelink W, Faas FG, Verkleij A, Rottier PJ, Koster AJ, Bosch BJ. Cryo-electron tomography of mouse hepatitis virus: insights into the structure of the coronavirion. Proc Natl Acad Sci USA. 2009;106:582\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1581_CR60","doi-asserted-by":"publisher","first-page":"7918","DOI":"10.1128\/JVI.00645-06","volume":"80","author":"BW Neuman","year":"2006","unstructured":"Neuman BW, Adair BD, Yoshioka C, Quispe JD, Orca G, Kuhn P, Milligan RA, Yeager M, Buchmeier MJ. Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy. J Virol. 2006;80:7918\u201328.","journal-title":"J Virol"},{"key":"1581_CR61","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41423-020-0377-z","volume":"17","author":"G Lucchese","year":"2020","unstructured":"Lucchese G. Epitopes for a 2019-nCoV vaccine. Cell Mol Immunol. 2020;17:539\u201340.","journal-title":"Cell Mol Immunol"},{"key":"1581_CR62","doi-asserted-by":"crossref","unstructured":"De Maio F, Lo Cascio E, Babini G, Sali M, Della Longa S, Tilocca B, Roncada P, Arcovito A, Sanguinetti M, Scambia G, Urbani A. Improved binding of SARS-CoV-2 envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis. Microbes Infect. 2020.","DOI":"10.1016\/j.micinf.2020.08.006"},{"key":"1581_CR63","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.3390\/v6082991","volume":"6","author":"R McBride","year":"2014","unstructured":"McBride R, van Zyl M, Fielding BC. The coronavirus nucleocapsid is a multifunctional protein. Viruses. 2014;6:2991\u20133018.","journal-title":"Viruses"},{"key":"1581_CR64","first-page":"7007","volume":"44","author":"JF Atkins","year":"2016","unstructured":"Atkins JF, Loughran G, Bhatt PR, Firth AE, Baranov PV. Ribosomal frameshifting and transcriptional slippage: from genetic steganography and cryptography to adventitious use. Nucleic Acids Res. 2016;44:7007\u201378.","journal-title":"Nucleic Acids Res"},{"key":"1581_CR65","doi-asserted-by":"crossref","unstructured":"Kelly JA, Dinman JD. Structural and functional conservation of the programmed -1 ribosomal frameshift signal of SARS-CoV-2. bioRxiv. 2020:2020.2003.2013.991083.","DOI":"10.1101\/2020.03.13.991083"},{"key":"1581_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","volume":"1282","author":"AR Fehr","year":"2015","unstructured":"Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1\u201323.","journal-title":"Methods Mol Biol"},{"key":"1581_CR67","doi-asserted-by":"publisher","first-page":"129","DOI":"10.12688\/f1000research.22457.2","volume":"9","author":"YW Chen","year":"2020","unstructured":"Chen YW, Yiu C-PB, Wong K-Y. Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL (pro)) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Research. 2020;9:129.","journal-title":"F1000Research"},{"key":"1581_CR68","doi-asserted-by":"crossref","unstructured":"Gao Y, Yan L, Huang Y, Liu F, Zhao Y, Cao L, Wang T, Sun Q, Ming Z, Zhang L, et al. Structure of RNA-dependent RNA polymerase from 2019-nCoV, a major antiviral drug target. bioRxiv. 2020:2020.2003.2016.993386.","DOI":"10.1101\/2020.03.16.993386"},{"key":"1581_CR69","doi-asserted-by":"publisher","first-page":"e1003565","DOI":"10.1371\/journal.ppat.1003565","volume":"9","author":"EC Smith","year":"2013","unstructured":"Smith EC, Blanc H, Surdel MC, Vignuzzi M, Denison MR. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics. PLoS Pathog. 2013;9:e1003565.","journal-title":"PLoS Pathog"},{"key":"1581_CR70","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1128\/JVI.01358-06","volume":"81","author":"SG Sawicki","year":"2007","unstructured":"Sawicki SG, Sawicki DL, Siddell SG. A contemporary view of coronavirus transcription. J Virol. 2007;81:20.","journal-title":"J Virol"},{"key":"1581_CR71","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/357420a0","volume":"357","author":"CL Yeager","year":"1992","unstructured":"Yeager CL, Ashmun RA, Williams RK, Cardellichio CB, Shapiro LH, Look AT, Holmes KV. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature. 1992;357:420\u20132.","journal-title":"Nature"},{"key":"1581_CR72","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature12005","volume":"495","author":"VS Raj","year":"2013","unstructured":"Raj VS, Mou H, Smits SL, Dekkers DH, M\u00fcller MA, Dijkman R, Muth D, Demmers JA, Zaki A, Fouchier RA, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495:251\u20134.","journal-title":"Nature"},{"key":"1581_CR73","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450\u20134.","journal-title":"Nature"},{"key":"1581_CR74","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1126\/science.1116480","volume":"309","author":"F Li","year":"2005","unstructured":"Li F, Li W, Farzan M, Harrison SC. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 2005;309:1864\u20138.","journal-title":"Science"},{"key":"1581_CR75","doi-asserted-by":"publisher","first-page":"e1004502","DOI":"10.1371\/journal.ppat.1004502","volume":"10","author":"C Burkard","year":"2014","unstructured":"Burkard C, Verheije MH, Wicht O, van Kasteren SI, van Kuppeveld FJ, Haagmans BL, Pelkmans L, Rottier PJM, Bosch BJ, de Haan CAM. Coronavirus cell entry occurs through the endo-\/lysosomal pathway in a proteolysis-dependent manner. PLoS Pathog. 2014;10:e1004502.","journal-title":"PLoS Pathog"},{"key":"1581_CR76","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.virusres.2014.11.021","volume":"202","author":"JK Millet","year":"2015","unstructured":"Millet JK, Whittaker GR. Host cell proteases: critical determinants of coronavirus tropism and pathogenesis. Virus Res. 2015;202:120\u201334.","journal-title":"Virus Res"},{"key":"1581_CR77","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/bs.aivir.2019.08.002","volume":"105","author":"MA Tortorici","year":"2019","unstructured":"Tortorici MA, Veesler D. Structural insights into coronavirus entry. Adv Virus Res. 2019;105:93\u2013116.","journal-title":"Adv Virus Res"},{"key":"1581_CR78","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature12328","volume":"500","author":"G Lu","year":"2013","unstructured":"Lu G, Hu Y, Wang Q, Qi J, Gao F, Li Y, Zhang Y, Zhang W, Yuan Y, Bao J, et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature. 2013;500:227\u201331.","journal-title":"Nature"},{"key":"1581_CR79","doi-asserted-by":"publisher","first-page":"7411","DOI":"10.1128\/JVI.00079-09","volume":"83","author":"IG Madu","year":"2009","unstructured":"Madu IG, Roth SL, Belouzard S, Whittaker GR. Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide. J Virol. 2009;83:7411\u201321.","journal-title":"J Virol"},{"key":"1581_CR80","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.1128\/JVI.02232-10","volume":"85","author":"I Glowacka","year":"2011","unstructured":"Glowacka I, Bertram S, Muller MA, Allen P, Soilleux E, Pfefferle S, Steffen I, Tsegaye TS, He Y, Gnirss K, et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol. 2011;85:4122\u201334.","journal-title":"J Virol"},{"key":"1581_CR81","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271-280.e278.","journal-title":"Cell"},{"key":"1581_CR82","doi-asserted-by":"crossref","unstructured":"Elbe S, Buckland-Merrett G. Data, disease and diplomacy: GISAID's innovative contribution to global health. In: Global challenges (Hoboken, NJ), vol. 1. pp. 33\u201346; 2017:33\u201346.","DOI":"10.1002\/gch2.1018"},{"key":"1581_CR83","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet. 2020;395:497\u2013506.","journal-title":"Lancet"},{"key":"1581_CR84","doi-asserted-by":"crossref","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020.","DOI":"10.1001\/jama.2020.1585"},{"key":"1581_CR85","doi-asserted-by":"crossref","unstructured":"Li J, Guo M, Tian X, Liu C, Wang X, Yang X, Wu P, Xiao Z, Qu Y, Yin Y, et al. Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis. bioRxiv. 2020:2020.2003.2031.019216.","DOI":"10.1101\/2020.03.31.019216"},{"key":"1581_CR86","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/infdis\/jiv380","volume":"213","author":"H Chu","year":"2015","unstructured":"Chu H, Zhou J, Wong BH-Y, Li C, Chan JF-W, Cheng Z-S, Yang D, Wang D, Lee AC-Y, Li C, et al. Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis. 2015;213:904\u201314.","journal-title":"J Infect Dis"},{"key":"1581_CR87","doi-asserted-by":"crossref","unstructured":"Wang X, Xu W, Hu G, Xia S, Sun Z, Liu Z, Xie Y, Zhang R, Jiang S, Lu L. SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion. Cell Mol Immunol. 2020.","DOI":"10.1038\/s41423-020-0424-9"},{"key":"1581_CR88","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367:1260\u20133.","journal-title":"Science"},{"key":"1581_CR89","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.micinf.2020.02.006","volume":"22","author":"JA Tetro","year":"2020","unstructured":"Tetro JA. Is COVID-19 receiving ADE from other coronaviruses? Microbes Infect. 2020;22:72\u20133.","journal-title":"Microbes Infect"},{"key":"1581_CR90","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","volume":"21","author":"Y Peng","year":"2020","unstructured":"Peng Y, Mentzer AJ, Liu G, Yao X, Yin Z, Dong D, Dejnirattisai W, Rostron T, Supasa P, Liu C, et al. Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat Immunol. 2020;21:1336\u201345.","journal-title":"Nat Immunol"},{"key":"1581_CR91","doi-asserted-by":"crossref","unstructured":"Mathew D, Giles JR, Baxter AE, Greenplate AR, Wu JE, Alanio C, Oldridge DA, Kuri-Cervantes L, Pampena MB, D'Andrea K, et al. Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions. bioRxiv. 2020.","DOI":"10.1101\/2020.05.20.106401"},{"key":"1581_CR92","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni A, Weiskopf D, Ramirez SI, Mateus J, Dan JM, Moderbacher CR, Rawlings SA, Sutherland A, Premkumar L, Jadi RS, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020;181:1489-1501.e1415.","journal-title":"Cell"},{"key":"1581_CR93","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/224038a0","volume":"224","author":"DC Dumonde","year":"1969","unstructured":"Dumonde DC, Wolstencroft RA, Panayi GS, Matthew M, Morley J, Howson WT. \u201cLymphokines\u201d: non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature. 1969;224:38\u201342.","journal-title":"Nature"},{"key":"1581_CR94","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1128\/JVI.01782-06","volume":"81","author":"SA Kopecky-Bromberg","year":"2007","unstructured":"Kopecky-Bromberg SA, Mart\u00ednez-Sobrido L, Frieman M, Baric RA, Palese P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol. 2007;81:548\u201357.","journal-title":"J Virol"},{"key":"1581_CR95","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","volume":"19","author":"R Channappanavar","year":"2016","unstructured":"Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK, Perlman S. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe. 2016;19:181\u201393.","journal-title":"Cell Host Microbe"},{"key":"1581_CR96","unstructured":"Lokugamage KG, Hage A, Schindewolf C, Rajsbaum R, Menachery VD. SARS-CoV-2 is sensitive to type I interferon pretreatment. bioRxiv. 2020:2020.2003.2007.982264."},{"key":"1581_CR97","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475\u201381.","journal-title":"Lancet Respir Med"},{"key":"1581_CR98","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239\u201342.","journal-title":"JAMA"},{"key":"1581_CR99","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s11882-013-0344-1","volume":"13","author":"ML Gavala","year":"2013","unstructured":"Gavala ML, Bashir H, Gern JE. Virus\/allergen interactions in asthma. Curr Allergy Asthma Rep. 2013;13:298\u2013307.","journal-title":"Curr Allergy Asthma Rep"},{"key":"1581_CR100","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/all.13593","volume":"74","author":"A Leino","year":"2019","unstructured":"Leino A, Lukkarinen M, Turunen R, Vuorinen T, S\u00f6derlund-Venermo M, Vahlberg T, Camargo CA Jr, Bochkov YA, Gern JE, Jartti T. Pulmonary function and bronchial reactivity 4 years after the first virus-induced wheezing. Allergy. 2019;74:518\u201326.","journal-title":"Allergy"},{"key":"1581_CR101","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijid.2016.06.015","volume":"49","author":"A Badawi","year":"2016","unstructured":"Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis. 2016;49:129\u201333.","journal-title":"Int J Infect Dis"},{"key":"1581_CR102","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1473-3099(09)70069-6","volume":"9","author":"J Lessler","year":"2009","unstructured":"Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DAT. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis. 2009;9:291\u2013300.","journal-title":"Lancet Infect Dis"},{"key":"1581_CR103","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/s12889-018-5484-8","volume":"18","author":"JE Park","year":"2018","unstructured":"Park JE, Jung S, Kim A, Park JE. MERS transmission and risk factors: a systematic review. BMC Public Health. 2018;18:574.","journal-title":"BMC Public Health"},{"key":"1581_CR104","unstructured":"Coronavirus Symptoms. https:\/\/www.who.int\/health-topics\/coronavirus#tab=tab_3."},{"key":"1581_CR105","doi-asserted-by":"crossref","unstructured":"Rodriguez-Morales AJ, Cardona-Ospina JA, Guti\u00e9rrez-Ocampo E, Villamizar-Pe\u00f1a R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020:101623.","DOI":"10.1016\/j.tmaid.2020.101623"},{"key":"1581_CR106","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jinf.2019.04.006","volume":"78","author":"R M\u00e9ndez","year":"2019","unstructured":"M\u00e9ndez R, Men\u00e9ndez R, Amara-Elori I, Feced L, Pir\u00f3 A, Ram\u00edrez P, Sempere A, Ortega A, Bermejo-Mart\u00edn JF, Torres A. Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortality. J Infect. 2019;78:423\u201331.","journal-title":"J Infect"},{"key":"1581_CR107","doi-asserted-by":"crossref","unstructured":"Liu J, Li S, Liu J, Liang B, Wang X, Wang H, Li W, Tong Q, Yi J, Zhao L, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. medRxiv. 2020:2020.2002.2016.20023671.","DOI":"10.1016\/j.ebiom.2020.102763"},{"key":"1581_CR108","unstructured":"Osborn M. Autopsy practice relating to possible cases of COVID-19 (2019-nCov, novel coronavirus from China 2019\/2020). Pathologists TRCo ed.; 2020."},{"key":"1581_CR109","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1136\/jclinpath-2020-206522","volume":"73","author":"B Hanley","year":"2020","unstructured":"Hanley B, Lucas SB, Youd E, Swift B, Osborn M. Autopsy in suspected COVID-19 cases. J Clin Pathol. 2020;73:239\u201342.","journal-title":"J Clin Pathol"},{"key":"1581_CR110","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ajpath.2015.10.024","volume":"186","author":"DL Ng","year":"2016","unstructured":"Ng DL, Al Hosani F, Keating MK, Gerber SI, Jones TL, Metcalfe MG, Tong S, Tao Y, Alami NN, Haynes LM, et al. Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of middle east respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014. Am J Pathol. 2016;186:652\u20138.","journal-title":"Am J Pathol"},{"key":"1581_CR111","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1016\/j.jcjo.2020.03.003","volume":"55","author":"M Cheema","year":"2020","unstructured":"Cheema M, Aghazadeh H, Nazarali S, Ting A, Hodges J, McFarlane A, Kanji JN, Zelyas N, Damji KF, Solarte C. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol. 2020;55:e125\u20139.","journal-title":"Can J Ophthalmol"},{"key":"1581_CR112","unstructured":"Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020. https:\/\/apps.who.int\/iris\/handle\/10665\/331329."},{"key":"1581_CR113","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/clinchem\/hvaa029","volume":"66","author":"DKW Chu","year":"2020","unstructured":"Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, Liu Y, Ng DYM, Wan CKC, Yang P, Wang Q, et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem. 2020;66:549\u201355.","journal-title":"Clin Chem"},{"key":"1581_CR114","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jama.2020.2565","volume":"323","author":"Y Bai","year":"2020","unstructured":"Bai Y, Yao L, Wei T, Tian F, Jin D-Y, Chen L, Wang M. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323:1406\u20137.","journal-title":"JAMA"},{"key":"1581_CR115","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1056\/NEJMc2001468","volume":"382","author":"C Rothe","year":"2020","unstructured":"Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, Zimmer T, Thiel V, Janke C, Guggemos W, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382:970\u20131.","journal-title":"N Engl J Med"},{"key":"1581_CR116","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/infdis\/jiaa077","volume":"221","author":"P Yu","year":"2020","unstructured":"Yu P, Zhu J, Zhang Z, Han Y, Huang L. A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period. J Infect Dis. 2020;221:1757\u201361.","journal-title":"J Infect Dis"},{"key":"1581_CR117","doi-asserted-by":"crossref","unstructured":"Walsh EE, Frenck RW, Jr., Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N Engl J Med. 2020.","DOI":"10.1056\/NEJMoa2027906"},{"key":"1581_CR118","doi-asserted-by":"crossref","unstructured":"Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, et al. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N Engl J Med. 2020.","DOI":"10.1056\/NEJMoa2028436"},{"key":"1581_CR119","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","volume":"396","author":"PM Folegatti","year":"2020","unstructured":"Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, Bellamy D, Bibi S, Bittaye M, Clutterbuck EA, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial. Lancet. 2020;396:467\u201378.","journal-title":"Lancet"},{"key":"1581_CR120","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S0140-6736(20)31866-3","volume":"396","author":"DY Logunov","year":"2020","unstructured":"Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, Shcheblyakov DV, Dzharullaeva AS, Grousova DM, Erokhova AS, Kovyrshina AV, Botikov AG, et al. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1\/2 studies from Russia. Lancet. 2020;396:887\u201397.","journal-title":"Lancet"},{"key":"1581_CR121","unstructured":"Coronavirus (COVID-19). https:\/\/covid-nma.com\/living_data\/index.php."},{"key":"1581_CR122","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ijtb.2020.07.031","volume":"67","author":"A Vora","year":"2020","unstructured":"Vora A, Arora VK, Behera D, Tripathy SK. White paper on Ivermectin as a potential therapy for COVID-19. Indian J Tuberc. 2020;67:448\u201351.","journal-title":"Indian J Tuberc"},{"key":"1581_CR123","doi-asserted-by":"publisher","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","volume":"178","author":"L Caly","year":"2020","unstructured":"Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antivir Res. 2020;178:104787.","journal-title":"Antivir Res"},{"key":"1581_CR124","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269\u201371.","journal-title":"Cell Res"},{"key":"1581_CR125","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature17180","volume":"531","author":"TK Warren","year":"2016","unstructured":"Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, Siegel D, Perron M, Bannister R, Hui HC, et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature. 2016;531:381\u20135.","journal-title":"Nature"},{"key":"1581_CR126","unstructured":"Treatments for COVID-19. https:\/\/www.health.harvard.edu\/diseases-and-conditions\/treatments-for-covid-19."},{"key":"1581_CR127","unstructured":"Lilly's neutralizing antibody bamlanivimab (LY-CoV555) receives FDA emergency use authorization for the treatment of recently diagnosed COVID-19. https:\/\/investor.lilly.com\/news-releases\/news-release-details\/lillys-neutralizing-antibody-bamlanivimab-ly-cov555-receives-fda#:~:text=Bamlanivimab%20is%20a%20recombinant%2C%20neutralizing,%2C%20potentially%20treating%20COVID%2D19."},{"key":"1581_CR128","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1743-422X-2-69","volume":"2","author":"MJ Vincent","year":"2005","unstructured":"Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, Seidah NG, Nichol ST. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005;2:69\u201369.","journal-title":"Virol J"},{"key":"1581_CR129","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","volume":"105","author":"L Oestereich","year":"2014","unstructured":"Oestereich L, L\u00fcdtke A, Wurr S, Rieger T, Mu\u00f1oz-Fontela C, G\u00fcnther S. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antivir Res. 2014;105:17\u201321.","journal-title":"Antivir Res"},{"key":"1581_CR130","doi-asserted-by":"crossref","unstructured":"Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, et al: Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci. 2020:202004168.","DOI":"10.1073\/pnas.2004168117"},{"key":"1581_CR131","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/jmv.25801","volume":"92","author":"P Luo","year":"2020","unstructured":"Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J. Tocilizumab treatment in COVID-19: a single center experience. J Med Virol. 2020;92:814\u20138.","journal-title":"J Med Virol"},{"key":"1581_CR132","unstructured":"Dong S, Sun J, Mao Z, Wang L, Lu Y-L, Li J. A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV). J Med Virol. n\/a."},{"key":"1581_CR133","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/s41594-020-0511-8","volume":"27","author":"K Schubert","year":"2020","unstructured":"Schubert K, Karousis ED, Jomaa A, Scaiola A, Echeverria B, Gurzeler LA, Leibundgut M, Thiel V, Muhlemann O, Ban N. SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation. Nat Struct Mol Biol. 2020;27:959\u201366.","journal-title":"Nat Struct Mol Biol"},{"key":"1581_CR134","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/jmv.25719","volume":"92","author":"S Angeletti","year":"2020","unstructured":"Angeletti S, Benvenuto D, Bianchi M, Giovanetti M, Pascarella S, Ciccozzi M. COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis. J Med Virol. 2020;92:584\u20138.","journal-title":"J Med Virol"},{"key":"1581_CR135","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.antiviral.2017.11.001","volume":"149","author":"J Lei","year":"2018","unstructured":"Lei J, Kusov Y, Hilgenfeld R. Nsp3 of coronaviruses: structures and functions of a large multi-domain protein. Antivir Res. 2018;149:58\u201374.","journal-title":"Antivir Res"},{"key":"1581_CR136","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1128\/JVI.02776-14","volume":"89","author":"DC Beachboard","year":"2015","unstructured":"Beachboard DC, Anderson-Daniels JM, Denison MR. Mutations across murine hepatitis virus nsp4 alter virus fitness and membrane modifications. J Virol. 2015;89:2080\u20139.","journal-title":"J Virol"},{"key":"1581_CR137","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1107\/S0907444909018253","volume":"65","author":"I Manolaridis","year":"2009","unstructured":"Manolaridis I, Wojdyla JA, Panjikar S, Snijder EJ, Gorbalenya AE, Berglind H, Nordlund P, Coutard B, Tucker PA. Structure of the C-terminal domain of nsp4 from feline coronavirus. Acta Crystallogr D Biol Crystallogr. 2009;65:839\u201346.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1581_CR138","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.virol.2016.12.005","volume":"502","author":"X Zhu","year":"2017","unstructured":"Zhu X, Fang L, Wang D, Yang Y, Chen J, Ye X, Foda MF, Xiao S. Porcine deltacoronavirus nsp5 inhibits interferon-\u03b2 production through the cleavage of NEMO. Virology. 2017;502:33\u20138.","journal-title":"Virology"},{"key":"1581_CR139","doi-asserted-by":"crossref","unstructured":"Angelini MM, Akhlaghpour M, Neuman BW, Buchmeier MJ. Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles. mBio. 2013;4.","DOI":"10.1128\/mBio.00524-13"},{"key":"1581_CR140","doi-asserted-by":"publisher","first-page":"108234","DOI":"10.1016\/j.celrep.2020.108234","volume":"33","author":"H Xia","year":"2020","unstructured":"Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, Menachery VD, Rajsbaum R, Shi PY. Evasion of type I interferon by SARS-CoV-2. Cell Rep. 2020;33:108234.","journal-title":"Cell Rep"},{"key":"1581_CR141","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1042\/BCJ20200029","volume":"477","author":"B Krichel","year":"2020","unstructured":"Krichel B, Falke S, Hilgenfeld R, Redecke L, Uetrecht C. Processing of the SARS-CoV pp1a\/ab nsp7-10 region. Biochem J. 2020;477:1009\u201319.","journal-title":"Biochem J"},{"key":"1581_CR142","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1038\/s41467-019-10280-3","volume":"10","author":"RN Kirchdoerfer","year":"2019","unstructured":"Kirchdoerfer RN, Ward AB. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nat Commun. 2019;10:2342.","journal-title":"Nat Commun"},{"key":"1581_CR143","doi-asserted-by":"publisher","first-page":"107548","DOI":"10.1016\/j.jsb.2020.107548","volume":"211","author":"E Konkolova","year":"2020","unstructured":"Konkolova E, Klima M, Nencka R, Boura E. Structural analysis of the putative SARS-CoV-2 primase complex. J Struct Biol. 2020;211:107548.","journal-title":"J Struct Biol"},{"key":"1581_CR144","doi-asserted-by":"crossref","unstructured":"Ong E, Wong MU, Huffman A, He Y. COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning. bioRxiv. 2020:2020.2003.2020.000141.","DOI":"10.1101\/2020.03.20.000141"},{"key":"1581_CR145","doi-asserted-by":"crossref","unstructured":"Mutlu O, Ugurel OM, Sariyer E, Ata O, Inci TG, Ugurel E, Kocer S, Turgut-Balik D. Targeting SARS-CoV-2 Nsp12\/Nsp8 interaction interface with approved and investigational drugs: an in silico structure-based approach. J Biomol Struct Dyn. 2020:1\u201313.","DOI":"10.1080\/07391102.2020.1819882"},{"key":"1581_CR146","doi-asserted-by":"publisher","first-page":"107774","DOI":"10.1016\/j.celrep.2020.107774","volume":"31","author":"Q Peng","year":"2020","unstructured":"Peng Q, Peng R, Yuan B, Zhao J, Wang M, Wang X, Wang Q, Sun Y, Fan Z, Qi J, et al. Structural and biochemical characterization of the nsp12-nsp7-nsp8 core polymerase complex from SARS-CoV-2. Cell Rep. 2020;31:107774.","journal-title":"Cell Rep"},{"key":"1581_CR147","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.1038\/s41598-020-61432-1","volume":"10","author":"K-J Jang","year":"2020","unstructured":"Jang K-J, Jeong S, Kang DY, Sp N, Yang YM, Kim D-E. A high ATP concentration enhances the cooperative translocation of the SARS coronavirus helicase nsP13 in the unwinding of duplex RNA. Sci Rep. 2020;10:4481.","journal-title":"Sci Rep"},{"key":"1581_CR148","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1080\/22221751.2020.1780953","volume":"9","author":"CK Yuen","year":"2020","unstructured":"Yuen CK, Lam JY, Wong WM, Mak LF, Wang X, Chu H, Cai JP, Jin DY, To KK, Chan JF, et al. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists. Emerg Microbes Infect. 2020;9:1418\u201328.","journal-title":"Emerg Microbes Infect"},{"key":"1581_CR149","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s12250-020-00242-1","volume":"35","author":"T Shu","year":"2020","unstructured":"Shu T, Huang M, Wu D, Ren Y, Zhang X, Han Y, Mu J, Wang R, Qiu Y, Zhang DY, Zhou X. SARS-coronavirus-2 Nsp13 possesses NTPase and RNA helicase activities that can be inhibited by bismuth salts. Virol Sin. 2020;35:321\u20139.","journal-title":"Virol Sin"},{"key":"1581_CR150","doi-asserted-by":"crossref","unstructured":"Ogando NS, Zevenhoven-Dobbe JC, van der Meer Y, Bredenbeek PJ, Posthuma CC, Snijder EJ. The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2. J Virol. 2020;94.","DOI":"10.1128\/JVI.01246-20"},{"key":"1581_CR151","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1002\/pro.3873","volume":"29","author":"Y Kim","year":"2020","unstructured":"Kim Y, Jedrzejczak R, Maltseva NI, Wilamowski M, Endres M, Godzik A, Michalska K, Joachimiak A. Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2. Protein Sci. 2020;29:1596\u2013605.","journal-title":"Protein Sci"},{"key":"1581_CR152","doi-asserted-by":"crossref","unstructured":"Zhang L, Li L, Yan L, Ming Z, Jia Z, Lou Z, Rao Z. Structural and biochemical characterization of endoribonuclease Nsp15 encoded by Middle East respiratory syndrome coronavirus. J Virol. 2018;92.","DOI":"10.1128\/JVI.00893-18"},{"key":"1581_CR153","doi-asserted-by":"publisher","first-page":"8416","DOI":"10.1128\/JVI.00948-15","volume":"89","author":"Y Wang","year":"2015","unstructured":"Wang Y, Sun Y, Wu A, Xu S, Pan R, Zeng C, Jin X, Ge X, Shi Z, Ahola T, et al. Coronavirus nsp10\/nsp16 methyltransferase can be targeted by nsp10-derived peptide in vitro and in vivo to reduce replication and pathogenesis. J Virol. 2015;89:8416\u201327.","journal-title":"J Virol"},{"key":"1581_CR154","unstructured":"ANDiS\u00ae SARS-CoV-2 RT-qPCR Detection Kit. http:\/\/www.3dmedcare.com\/covid\/."},{"key":"1581_CR155","unstructured":"Abbott RealTime SARS-CoV-2 EUA test. https:\/\/www.molecular.abbott\/int\/en\/products\/infectious-disease\/RealTime-SARS-CoV-2-Assay."},{"key":"1581_CR156","unstructured":"Truenat\u2122 Beta CoV (lab-based or near-POC). http:\/\/www.molbiodiagnostics.com\/product_details.php?id=54."},{"key":"1581_CR157","unstructured":"QIAstat-Dx SARS-CoV-2. https:\/\/corporate.qiagen.com\/newsroom\/press-releases\/2020\/20200331_fda_eua."},{"key":"1581_CR158","unstructured":"cobas\u00ae SARS-CoV-2 test. https:\/\/diagnostics.roche.com\/global\/en\/products\/params\/cobas-sars-cov-2-test.html."},{"key":"1581_CR159","unstructured":"Senteligo Covid-19 qRT PCR Detection Kit. https:\/\/www.eryigit.com.tr\/en\/coronavirus-detection-kit-2\/."},{"key":"1581_CR160","unstructured":"VereCoV\u2122 Detection Kit for Diagnosis of COVID-19. https:\/\/vereduslabs.com\/news-and-resources\/."},{"key":"1581_CR161","unstructured":"VISION COVID19 Easyprep Test Kit. www.ageback.com\/visionby."},{"key":"1581_CR162","unstructured":"ePlex\u00ae SARS-CoV-2 Test. http:\/\/ir.genmarkdx.com\/news-releases\/news-release-details\/genmark-receives-fda-emergency-use-authorization-its-eplexr-sars."},{"key":"1581_CR163","unstructured":"Accu-Tell COVID-19 IgG\/IgM Rapid Test Cassette Specimen: Whole blood\/Serum\/Plasma. www.accubiotech.com\/product-covid-19-igg-igm-rapid-test-cassette-(whole-blood-serum-plasma).html."},{"key":"1581_CR164","unstructured":"SARS-CoV-2 IgM\/IgG antibody test kit (Colloidal Gold Method). http:\/\/www.biohit.cn\/."},{"key":"1581_CR165","unstructured":"COVID-19 IgM\/IgG Rapid Test. https:\/\/www.biomedomics.com\/products\/infectious-disease\/covid-19-rt\/."},{"key":"1581_CR166","unstructured":"Cellex qSARS-COV-2 IgG\/IgM Rapid Test Specimen: whole blood\/Serum\/Plasma. https:\/\/cellex.us\/sporducts\/?id=125&t=44."},{"key":"1581_CR167","unstructured":"Human Anti-SARS-CoV-2 (Covid-19) IgG\/IgM Rapid Test. https:\/\/www.krishgen.com\/products.php?category=coronavirus-reagents-and-kits."},{"key":"1581_CR168","unstructured":"SARS-CoV-2 IgM\/IgG Ab Rapid Test Specimen: WB\/S\/P. www.surebiotech.com\/rapid-test\/coronavirus-covid-19-rapid-test\/."},{"key":"1581_CR169","volume-title":"Draft landscape of COVID-19 candidate vaccines","author":"WHO","year":"2020","unstructured":"WHO. Draft landscape of COVID-19 candidate vaccines. Geneva: WHO; 2020."},{"key":"1581_CR170","unstructured":"PRE-VENT study in hospitalized patients with severe COVID-19 with or without cancer. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04404361."},{"key":"1581_CR171","unstructured":"Full dose heparin vs. prophylactic or intermediate dose heparin in high risk COVID-19 patients. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04401293."},{"key":"1581_CR172","unstructured":"Adaptive COVID-19 Treatment Trial 2 (ACTT-2). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04401579."},{"key":"1581_CR173","doi-asserted-by":"crossref","unstructured":"Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020:105949.","DOI":"10.1101\/2020.03.16.20037135"},{"key":"1581_CR174","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5582\/bst.2020.01047","volume":"14","author":"J Gao","year":"2020","unstructured":"Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14:72\u20133.","journal-title":"Biosci Trends"},{"key":"1581_CR175","doi-asserted-by":"crossref","unstructured":"Cai Q, Yang M, Liu D, Chen J, Shu D, Xia J, Liao X, Gu Y, Cai Q, Yang Y, et al. Experimental treatment with favipiravir for COVID-19: an open-label control study. Engineering. 2020.","DOI":"10.1016\/j.eng.2020.03.007"},{"key":"1581_CR176","unstructured":"A randomized, open, controlled clinical study to evaluate the efficacy of ASC09F and ritonavir for 2019-nCoV pneumonia. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04261270."},{"key":"1581_CR177","unstructured":"Anti-il6 treatment of serious COVID-19 disease with threatening respiratory failure (TOCIVID). https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04322773."},{"key":"1581_CR178","unstructured":"A Study in patients with COVID-19 and respiratory distress not requiring mechanical ventilation, to compare Standard-of-care with anakinra and tocilizumab treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04412291."},{"key":"1581_CR179","unstructured":"Prophylactic ivermectin in COVID-19 contacts. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04422561."},{"key":"1581_CR180","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/S2213-2600(20)30314-3","volume":"8","author":"DV Nicolau","year":"2020","unstructured":"Nicolau DV, Bafadhel M. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19? Lancet Respir Med. 2020;8:846\u20137.","journal-title":"Lancet Respir Med"},{"key":"1581_CR181","doi-asserted-by":"crossref","unstructured":"Chen P, Nirula A, Heller B, Gottlieb RL, Boscia J, Morris J, Huhn G, Cardona J, Mocherla B, Stosor V, et al. SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19. N Engl J Med. 2020.","DOI":"10.1056\/NEJMoa2029849"},{"key":"1581_CR182","unstructured":"NA-831, atazanavir and dexamethasone combination therapy for the treatment of COVID-19 infection (NATADEX). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04452565."},{"key":"1581_CR183","unstructured":"Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) (COVID-19). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04322682."},{"key":"1581_CR184","unstructured":"Randomised evaluation of COVID-19 therapy (RECOVERY). https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT04381936."}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01581-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-020-01581-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01581-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:56:29Z","timestamp":1669902989000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-020-01581-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":184,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1581"],"URL":"https:\/\/doi.org\/10.1186\/s12931-020-01581-z","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"26 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"318"}}